Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | LOX | P28300 | 1/20 | 0.37 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5155235 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TDP1TSHRLOXLOXL3 | |
| SCHEMBL8323691 | 0.96 | ALDH1A1 (0.56) | ALDH1A1TDP1TSHRLOXLOXL3 | |
| SCHEMBL8323693 | 0.96 | ALDH1A1 (0.56) | ALDH1A1TDP1TSHRLOXLOXL3 | |
| SCHEMBL17511075 | 0.86 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHR | |
| SCHEMBL17532630 | 0.86 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHR | |
| SCHEMBL5912348 | 0.86 | ALDH1A1 (0.42) | ALDH1A1TDP1 | |
| SCHEMBL17511103 | 0.86 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHR | |
| SCHEMBL21433096 | 0.86 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHR | |
| SCHEMBL21433095 | 0.86 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHR | |
| SCHEMBL5912343 | 0.86 | ALDH1A1 (0.42) | ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1323707-B1 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | UBE INDUSTRIES (JP) | 2007-01-24 | — | — | EP | claimed |
| US-6689895-B2 | 4, 8-dodecadienedinitrile and process for its production | UBE INDUSTRIES, LTD. (JP) | 2004-02-10 | — | — | US | claimed |
| US-20030181751-A1 | 4, 8-dodecadienedinitrile and process for its production | UBE INDUSTRIES (JP) | 2003-09-25 | — | — | US | claimed |
| EP-1323707-A1 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | Ube Industries, Ltd. (JP) | 2003-07-02 | — | — | EP | claimed |
| US-4133726-A | Electrolytic flow-cell apparatus and process for effecting sequential electrochemical reaction | MONSANTO COMPANY (US) | 1979-01-09 | — | — | US | claimed |
| EP-1323707-B1 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | UBE INDUSTRIES (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1323707-B1 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | UBE INDUSTRIES (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1323707-B1 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | UBE INDUSTRIES (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1323707-A4 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | UBE INDUSTRIES (JP) | 2005-08-17 | — | — | EP | disclosed |
| US-6689895-B2 | 4, 8-dodecadienedinitrile and process for its production | UBE INDUSTRIES, LTD. (JP) | 2004-02-10 | — | — | US | disclosed |
| US-6689895-B2 | 4, 8-dodecadienedinitrile and process for its production | UBE INDUSTRIES, LTD. (JP) | 2004-02-10 | — | — | US | disclosed |
| US-6689895-B2 | 4, 8-dodecadienedinitrile and process for its production | UBE INDUSTRIES, LTD. (JP) | 2004-02-10 | — | — | US | disclosed |
| US-20030181751-A1 | 4, 8-dodecadienedinitrile and process for its production | UBE INDUSTRIES (JP) | 2003-09-25 | — | — | US | disclosed |
| US-20030181751-A1 | 4, 8-dodecadienedinitrile and process for its production | UBE INDUSTRIES (JP) | 2003-09-25 | — | — | US | disclosed |
| EP-1323707-A1 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | Ube Industries, Ltd. (JP) | 2003-07-02 | — | — | EP | disclosed |
| EP-1323707-A1 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | Ube Industries, Ltd. (JP) | 2003-07-02 | — | — | EP | disclosed |
| JP-2002088045-A | 4,8-DODECADIENEDINITRILE | UBE IND LTD | 2002-03-27 | — | — | JP | disclosed |
| WO-2002022560-A1 | 4,8-DODECADIENEDINITRILE AND PROCESS FOR ITS PRODUCTION | UBE INDUSTRIES, LTD. (JP) | 2002-03-21 | — | — | WO | disclosed |
| US-4133726-A | Electrolytic flow-cell apparatus and process for effecting sequential electrochemical reaction | MONSANTO COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4071429-A | Electrolytic flow-cell apparatus and process for effecting sequential electrochemical reaction | MONSANTO COMPANY (US) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181751-A1 | 4, 8-dodecadienedinitrile and process for its production | HSD17B7, CYP8B1, HSD11B1 | ALDH1A1 488/4885TDP1 2394/4885TSHR 2071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.